Pullen Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.31M Sell
10,855
-174
-2% -$20.1K 0.66% 62
2025
Q4
$1.16M Sell
11,029
-69
-0.6% -$6.48K 0.61% 64
2025
Q3
$931K Buy
11,098
+66
+0.6% +$5.44K 0.5% 72
2025
Q2
$873K Sell
11,032
-689
-6% -$54.8K 0.53% 73
2025
Q1
$1.05M Buy
11,721
+235
+2% +$21.9K 0.66% 62
2024
Q4
$1.14M Sell
11,486
-1,348
-11% -$139K 0.74% 53
2024
Q3
$1.46M Buy
12,834
+148
+1% +$17.6K 1.07% 34
2024
Q2
$1.57M Sell
12,686
-9,659
-43% -$1.24M 1.3% 23
2024
Q1
$2.95M Buy
+22,345
New +$2.75M 2.49% 7

Other funds holding MRK

Pullen Investment Management's MRK Position: Q1 2026 in Review

Pullen Investment Management reduced its Merck (MRK) stake by 1.6% in Q1 2026, selling an estimated $20.1K and leaving 10,855 shares worth $1.31M. The position accounts for 0.66% of the portfolio, ranked #62.

Pullen Investment Management first reported a position in MRK in Q1 2024 and has held it in 9 quarters since. The position peaked at $2.95M in Q1 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Pullen Investment Management held 10,855 shares of Merck worth $1.31M as of Q1 2026.
  • Pullen Investment Management sold 174 Merck shares in Q1 2026, an estimated $20.1K.
  • Merck made up 0.66% of Pullen Investment Management's portfolio in Q1 2026, its #62 holding.
  • Pullen Investment Management first reported a position in Merck in Q1 2024 and has held it in 9 quarters since.
  • Pullen Investment Management's Merck position peaked at $2.95M in Q1 2024.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Pullen Investment Management's 13F filing for Q1 2026, filed 15 Apr 2026.